NEURALTUS PHARMACEUTICALS, INC.; INC.;NEURALTUS PHARMACEUTICALS;THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
发明人:
MCGRATH, MICHAEL, S.,AZHIR, ARASTEH, ARI
申请号：
EP10806852
公开号：
EP2461694A4
申请日:
2010.07.23
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
The present invention provides a method of treating a macrophage related disease comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The present invention also provides a method of modulating macrophage accumulation or activation comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The oxidative agent can be chlorite or a chlorite containing compound.
